Global Genome Editing Market Size, Share, and COVID-19 Impact Analysis, By Technology (CRISPR/Cas9, TALENs/MegaTALs, ZFN, Mega Nuclease, Others), By Delivery Mode (Ex-vivo and In-vitro), By Application (Genetic Engineering, and Clinical Applications), By Mode (Contract and In-House), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

1. Introduction

1.1. Objectives of the Study

1.2. Market Definition

1.3. Research Scope

1. Research Methodology and Assumptions
2. Executive Summary
3. Premium Insights

4.1. Porter’s Five Forces Analysis

4.2. Value Chain Analysis

4.3. Top Investment Pockets

4.3.1. Market Attractiveness Analysis By Technology

4.3.2. Market Attractiveness Analysis By Delivery Mode

4.3.3. Market Attractiveness Analysis By Application

4.3.4. Market Attractiveness Analysis By Mode

4.3.5. Market Attractiveness Analysis By Region

4.4. Industry Trends

1. Market Dynamics

5.1. Market Evaluation

5.2. Drivers

5.2.1 growing number of genetic illnesses and abnormalities

5.2.2 Commercialization and development of genome editing technologies

5.3. Restraints

5.3.1. high cost of genomic equipment and ethical issues surrounding genetic research

5.4. Opportunities

5.4.1. Expanding pipeline for gene therapy

5.5. Challenges

5.5.1. High equipment costs

1. Global Genome Editing Market Analysis and Projection, By Technology

6.1. Segment Overview

6.2. Ex-vivo

6.3. TALENs/MegaTALs

6.4. ZFN

6.5. Mega nuclease

6.6. Others

1. Global Genome Editing Market Analysis and Projection, By Delivery Mode

7.1. Segment Overview

7.2. Ex-vivo

7.3. In-vitro

1. Global Genome Editing Market Analysis and Projection, By Application

8.1. Segment Overview

8.2. Genetic Engineering

8.3. Clinical Delivery Modes

1. Global Genome Editing Market Analysis and Projection, By Mode

9.1. Segment Overview

9.2. Contract

9.3. In-house

1. Global Genome Editing Market Analysis and Projection, By Regional Analysis

10.1. Segment Overview

10.2. North America

10.2.1. U.S.

10.2.2. Canada

10.2.3. Mexico

10.3. Europe

10.3.1. Germany

10.3.2. France

10.3.3. U.K.

10.3.4. Italy

10.3.5. Spain

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.5. South America

10.5.1. Brazil

10.6. Middle East and Africa

10.6.1. UAE

10.6.2. South Africa

1. Global Genome Editing Market-Competitive Landscape

11.1. Overview

11.2. Market Share of Key Players in the Genome Editing Market

11.2.1. Global Company Market Share

11.2.2. North America Company Market Share

11.2.3. Europe Company Market Share

11.2.4. APAC Company Market Share

11.3. Competitive Situations and Trends

11.3.1. Coverage Launches and Developments

11.3.2. Partnerships, Collaborations, and Agreements

11.3.3. Mergers & Acquisitions

11.3.4. Expansions

1. Company Profiles

12.1.         Merck KGaA

12.1.1. Business Overview

12.1.2. Company Snapshot

12.1.3. Company Market Share Analysis

12.1.4. Company Coverage Portfolio

12.1.5. Recent Developments

12.1.6. SWOT Analysis

12.2.         Cibus Inc.

12.2.1. Business Overview

12.2.2. Company Snapshot

12.2.3. Company Market Share Analysis

12.2.4. Company Coverage Portfolio

12.2.5. Recent Developments

12.2.6. SWOT Analysis

12.3.         Recombinetics  

12.3.1. Business Overview

12.3.2. Company Snapshot

12.3.3. Company Market Share Analysis

12.3.4. Company Coverage Portfolio

12.3.5. Recent Developments

12.3.6. SWOT Analysis

12.4.          Sangamo Therapeutics

12.4.1. Business Overview

12.4.2. Company Snapshot

12.4.3. Company Market Share Analysis

12.4.4. Company Coverage Portfolio

12.4.5. Recent Developments

12.4.6. SWOT Analysis

12.5.         Editas Medicine

12.5.1. Business Overview

12.5.2. Company Snapshot

12.5.3. Company Market Share Analysis

12.5.4. Company Coverage Portfolio

12.5.5. Recent Developments

12.5.6. SWOT Analysis

12.6.         Precision Biosciences

12.6.1. Business Overview

12.6.2. Company Snapshot

12.6.3. Company Market Share Analysis

12.6.4. Company Coverage Portfolio

12.6.5. Recent Developments

12.6.6. SWOT Analysis

12.7.         CRISPR Therapeutics

12.7.1. Business Overview

12.7.2. Company Snapshot

12.7.3. Company Market Share Analysis

12.7.4. Company Coverage Portfolio

12.7.5. Recent Developments

12.7.6. SWOT Analysis

12.8.          Intellia Therapeutics, Inc

12.8.1. Business Overview

12.8.2. Company Snapshot

12.8.3. Company Market Share Analysis

12.8.4. Company Coverage Portfolio

12.8.5. Recent Developments

12.8.6. SWOT Analysis

12.9.         Cellectis S.A.

12.9.1. Business Overview

12.9.2. Company Snapshot

12.9.3. Company Market Share Analysis

12.9.4. Company Coverage Portfolio

12.9.5. Recent Developments

12.9.6. SWOT Analysis

12.10.         Caribou Biosciences, Inc 

12.10.1. Business Overview

12.10.2. Company Snapshot

12.10.3. Company Market Share Analysis

12.10.4. Company Coverage Portfolio

12.10.5. Recent Developments

12.10.6. SWOT Analysis

12.11.         AstraZeneca

12.11.1. Business Overview

12.11.2. Company Snapshot

12.11.3. Company Market Share Analysis

12.11.4. Company Coverage Portfolio

12.11.5. Recent Developments

12.11.6. SWOT Analysis

12.12.         Takara Bio Inc.

12.12.1. Business Overview

12.12.2. Company Snapshot

12.12.3. Company Market Share Analysis

12.12.4. Company Coverage Portfolio

12.12.5. Recent Developments

12.12.6. SWOT Analysis

12.13.         Horizon Discovery Ltd. (Revvity, Inc.)

12.13.1. Business Overview

12.13.2. Company Snapshot

12.13.3. Company Market Share Analysis

12.13.4. Company Coverage Portfolio

12.13.5. Recent Developments

12.13.6. SWOT Analysis

12.14.         Danaher Corporation

12.14.1. Business Overview

12.14.2. Company Snapshot

12.14.3. Company Market Share Analysis

12.14.4. Company Coverage Portfolio

12.14.5. Recent Developments

12.14.6. SWOT Analysis

12.15.         Trasposagen Biopharmaceuticals, Inc.

12.15.1. Business Overview

12.15.2. Company Snapshot

12.15.3. Company Market Share Analysis

12.15.4. Company Coverage Portfolio

12.15.5. Recent Developments

12.15.6. SWOT Analysis

12.16.          Others

12.16.1. Business Overview

12.16.2. Company Snapshot

12.16.3. Company Market Share Analysis

12.16.4. Company Coverage Portfolio

12.16.5. Recent Developments

12.16.6. SWOT Analysis

 

1. Global Genome Editing Market, By Technology, 2023-2033(USD Billion)
2. Global (CRISPR)/Cas9, Genome Editing Market, By Region, 2023-2033(USD Billion)
3. Global TALENs/MegaTALs, Genome Editing Market, By Region, 2023-2033(USD Billion)
4. Global ZFN, Genome Editing Market, By Region, 2023-2033(USD Billion)
5. Global Mega nuclease, Genome Editing Market, By Region, 2023-2033(USD Billion)
6. Global Others, Genome Editing Market, By Region, 2023-2033(USD Billion)
7. Global Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
8. Global Ex-vivo, Genome Editing Market, By Region, 2023-2033(USD Billion)
9. Global In-vitro, Genome Editing Market, By Region, 2023-2033(USD Billion)
10. Global Genome Editing Market, By Application, 2023-2033(USD Billion)
11. Global Genetic Engineering, Genome Editing Market, By Region, 2023-2033(USD Billion)
12. Global Clinical Delivery Modes, Genome Editing Market, By Region, 2023-2033(USD Billion)
13. Global Genome Editing Market, By Mode, 2023-2033(USD Billion)
14. Global Contract, Genome Editing Market, By Region, 2023-2033(USD Billion)
15. Global In-house, Genome Editing Market, By Region, 2023-2033(USD Billion)
16. North America Genome Editing Market, By Technology, 2023-2033(USD Billion)
17. North America Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
18. North America Genome Editing Market, By Application, 2023-2033(USD Billion)
19. North America Genome Editing Market, By Mode, 2023-2033(USD Billion)
20. U.S.  Genome Editing Market, By Technology, 2023-2033(USD Billion)
21. U.S.  Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
22. U.S.  Genome Editing Market, By Application, 2023-2033(USD Billion)
23. U.S.  Genome Editing Market, By Mode, 2023-2033(USD Billion)
24. Canada Genome Editing Market, By Technology, 2023-2033(USD Billion)
25. Canada Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
26. Canada Genome Editing Market, By Application, 2023-2033(USD Billion)
27. Canada Genome Editing Market, By Mode, 2023-2033(USD Billion)
28. Mexico Genome Editing Market, By Technology, 2023-2033(USD Billion)
29. Mexico Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
30. Mexico Genome Editing Market, By Application, 2023-2033(USD Billion)
31. Mexico Genome Editing Market, By Mode, 2023-2033(USD Billion)
32. Europe Genome Editing Market, By Technology, 2023-2033(USD Billion)
33. Europe Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
34. Europe Genome Editing Market, By Application, 2023-2033(USD Billion)
35. Europe Genome Editing Market, By Mode, 2023-2033(USD Billion)
36. Germany Genome Editing Market, By Technology, 2023-2033(USD Billion)
37. Germany Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
38. Germany Genome Editing Market, By Application, 2023-2033(USD Billion)
39. Germany Genome Editing Market, By Mode, 2023-2033(USD Billion)
40. France Genome Editing Market, By Technology, 2023-2033(USD Billion)
41. France Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
42. France Genome Editing Market, By Application, 2023-2033(USD Billion)
43. France Genome Editing Market, By Mode, 2023-2033(USD Billion)
44. U.K.  Genome Editing Market, By Technology, 2023-2033(USD Billion)
45. U.K.  Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
46. U.K.  Genome Editing Market, By Application, 2023-2033(USD Billion)
47. U.K.  Genome Editing Market, By Mode, 2023-2033(USD Billion)
48. Italy Genome Editing Market, By Technology, 2023-2033(USD Billion)
49. Italy Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
50. Italy Genome Editing Market, By Application, 2023-2033(USD Billion)
51. Italy Genome Editing Market, By Mode, 2023-2033(USD Billion)
52. Spain Genome Editing Market, By Technology, 2023-2033(USD Billion)
53. Spain Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
54. Spain Genome Editing Market, By Application, 2023-2033(USD Billion)
55. Spain Genome Editing Market, By Mode, 2023-2033(USD Billion)
56. Asia Pacific Genome Editing Market, By Technology, 2023-2033(USD Billion)
57. Asia Pacific Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
58. Asia Pacific Genome Editing Market, By Application, 2023-2033(USD Billion)
59. Asia Pacific Genome Editing Market, By Mode, 2023-2033(USD Billion)
60. Japan Genome Editing Market, By Technology, 2023-2033(USD Billion)
61. Japan Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
62. Japan Genome Editing Market, By Application, 2023-2033(USD Billion)
63. Japan Genome Editing Market, By Mode, 2023-2033(USD Billion)
64. China Genome Editing Market, By Technology, 2023-2033(USD Billion)
65. China Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
66. China Genome Editing Market, By Application, 2023-2033(USD Billion)
67. China Genome Editing Market, By Mode, 2023-2033(USD Billion)
68. India Genome Editing Market, By Technology, 2023-2033(USD Billion)
69. India Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
70. India Genome Editing Market, By Application, 2023-2033(USD Billion)
71. India Genome Editing Market, By Mode, 2023-2033(USD Billion)
72. South America Genome Editing Market, By Technology, 2023-2033(USD Billion)
73. South America Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
74. South America Genome Editing Market, By Application, 2023-2033(USD Billion)
75. South America Genome Editing Market, By Mode, 2023-2033(USD Billion)
76. Brazil Genome Editing Market, By Technology, 2023-2033(USD Billion)
77. Brazil Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
78. Brazil Genome Editing Market, By Application, 2023-2033(USD Billion)
79. Brazil Genome Editing Market, By Mode, 2023-2033(USD Billion)
80. The Middle East and Africa Genome Editing Market, By Technology, 2023-2033(USD   Billion)
81. The Middle East and Africa Genome Editing Market, By Delivery Mode, 2023-2033(USD   Billion)
82. The Middle East and Africa Genome Editing Market, By Application, 2023-2033(USD Billion)
83. The Middle East and Africa Genome Editing Market, By Mode, 2023-2033(USD Billion)
84. UAE Genome Editing Market, By Technology, 2023-2033(USD Billion)
85. UAE Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
86. UAE Genome Editing Market, By Application, 2023-2033(USD Billion)
87. UAE Genome Editing Market, By Mode, 2023-2033(USD Billion) 
88. South Africa Genome Editing Market, By Technology, 2023-2033(USD Billion)
89. South Africa Genome Editing Market, By Delivery Mode, 2023-2033(USD Billion)
90. South Africa Genome Editing Market, By Application, 2023-2033(USD Billion)
91. South Africa Genome Editing Market, By Mode, 2023-2033(USD Billion)

1. Global Genome Editing Market Segmentation
2. Genome Editing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Top investment pocket in the Genome Editing Market
9. Top Winning Strategies, 2023-2033
10. Top Winning Strategies, By Development, 2023-2033(%)
11. Top Winning Strategies, By Company, 2023-2033
12. Moderate Bargaining power of Buyers
13. Moderate Bargaining power of Suppliers
14. Moderate Bargaining power of New Entrants
15. Low threat of Substitution
16. High Competitive Rivalry
17. Top Player Positioning, 2023
18. Market Share Analysis, 2023
19. Restraint and Drivers:  Genome Editing Market
20. Genome Editing Market Segmentation, By Technology
21. Genome Editing Market For (CRISPR)/Cas9, By Region, 2023-2033 ($ Billion)
22. Genome Editing Market For TALENs/MegaTALs, By Region, 2023-2033 ($ Billion)
23. Genome Editing Market For ZFN, By Region, 2023-2033 ($ Billion)
24. Genome Editing Market For Mega nuclease, By Region, 2023-2033 ($ Billion)
25. Genome Editing Market For Others, By Region, 2023-2033 ($ Billion)
26. Genome Editing Market Segmentation, By Delivery Mode
27.  Genome Editing Market For Ex-vivo, By Region, 2023-2033 ($ Billion)
28.  Genome Editing Market For In-vitro, By Region, 2023-2033 ($ Billion)
29. Genome Editing Market Segmentation, By Application
30. Genome Editing Market For Genetic Engineering, By Region, 2023-2033 ($ Billion)
31. Genome Editing Market For Clinical Delivery Modes, By Region, 2023-2033 ($ Billion)
32. Genome Editing Market Segmentation, By Mode
33. Genome Editing Market For Contract, By Region, 2023-2033 ($ Billion)
34. Genome Editing Market For In-house, By Region, 2023-2033 ($ Billion)
35. Merck KGaA: Net Sales, 2023-2033 ($ Billion)
36. Merck KGaA: Revenue Share, By Segment, 2023 (%)
37. Merck KGaA: Revenue Share, By Region, 2023 (%)
38. Cibus Inc.: Net Sales, 2023-2033 ($ Billion)
39. Cibus Inc.: Revenue Share, By Segment, 2023 (%)
40. Cibus Inc.: Revenue Share, By Region, 2023 (%)
41. Recombinetics: Net Sales, 2023-2033 ($ Billion)
42. Recombinetics: Revenue Share, By Segment, 2023 (%)
43. Recombinetics: Revenue Share, By Region, 2023 (%)
44. Sangamo Therapeutics: Net Sales, 2023-2033 ($ Billion)
45. Sangamo Therapeutics: Revenue Share, By Segment, 2023 (%)
46. Sangamo Therapeutics: Revenue Share, By Region, 2023 (%)
47. Editas Medicine: Net Sales, 2023-2033 ($ Billion)
48. Editas Medicine: Revenue Share, By Segment, 2023 (%)
49. Editas Medicine: Revenue Share, By Region, 2023 (%)
50. Precision Biosciences: Net Sales, 2023-2033 ($ Billion)
51. Precision Biosciences: Revenue Share, By Segment, 2023 (%)
52. Precision Biosciences: Revenue Share, By Region, 2023 (%)
53. CRISPR Therapeutics: Net Sales, 2023-2033 ($ Billion)
54. CRISPR Therapeutics: Revenue Share, By Segment, 2023 (%)
55. CRISPR Therapeutics: Revenue Share, By Region, 2023 (%)
56. Intellia Therapeutics, Inc: Net Sales, 2023-2033 ($ Billion)
57. Intellia Therapeutics, Inc: Revenue Share, By Segment, 2023 (%)
58. Intellia Therapeutics, Inc: Revenue Share, By Region, 2023 (%)
59. Cellectis S.A.: Net Sales, 2023-2033 ($ Billion)
60. Cellectis S.A.: Revenue Share, By Segment, 2023 (%)
61. Cellectis S.A.: Revenue Share, By Region, 2023 (%)
62. Caribou Biosciences, Inc: Net Sales, 2023-2033 ($ Billion)
63. Caribou Biosciences, Inc: Revenue Share, By Segment, 2023 (%)
64. Caribou Biosciences, Inc: Revenue Share, By Region, 2023 (%)
65. AstraZeneca: Net Sales, 2023-2033 ($ Billion)
66. AstraZeneca: Revenue Share, By Segment, 2023 (%)
67. AstraZeneca: Revenue Share, By Region, 2023 (%)
68. Takara Bio Inc.: Net Sales, 2023-2033 ($ Billion)
69. Takara Bio Inc.: Revenue Share, By Segment, 2023 (%)
70. Takara Bio Inc.: Revenue Share, By Region, 2023 (%)
71. Horizon Discovery Ltd. (Revvity, Inc.): Net Sales, 2023-2033 ($ Billion)
72. Horizon Discovery Ltd. (Revvity, Inc.): Revenue Share, By Segment, 2023 (%)
73. Horizon Discovery Ltd. (Revvity, Inc.): Revenue Share, By Region, 2023 (%)
74. Danaher Corporation: Net Sales, 2023-2033 ($ Billion)
75. Danaher Corporation: Revenue Share, By Segment, 2023 (%)
76. Danaher Corporation: Revenue Share, By Region, 2023 (%)
77. Trasposagen Biopharmaceuticals, Inc.: Net Sales, 2023-2033 ($ Billion)
78. Trasposagen Biopharmaceuticals, Inc.: Revenue Share, By Segment, 2023 (%)
79. Trasposagen Biopharmaceuticals, Inc.: Revenue Share, By Region, 2023 (%)
80. Others: Net Sales, 2023-2033 ($ Billion)
81. Others: Revenue Share, By Segment, 2023 (%)
82. Others: Revenue Share, By Region, 2023 (%)